Farmacovigilancia en paciente adulto mayor con la enfermedad de síndrome de insuficiencia renal crónica

Abstract

Pharmacovigilance has been considerably important worldwide throughout time to guarantee the safety in the prescription of medicines, the beginning was in 1848 when controversial cases of adverse reactions related to anesthetics occurred, since then until nowadays pharmacovigilance has the purpose of supervising the use of medicines to improve the patient's health. At the end of the XVIII century some syndromes of renal diseases were described, then with the passing of time researchers described more information in the field of nephrology, such investigations executed until today have cooperated efficiently in order to battle with the mortality rate that such disease has procreated. Renal failure represents a high percentage of deaths around the world, since this disease is very frequent in adults with a history of diabetes. The objective of the subsequent study is to analyze and identify the causes of renal failure disease in adult patients, through a severe diagnosis of the factors and consequences associated with CKD, in order to apply pharmacovigilance in the treatment appropriate to the patient's needs. The current document details the symptoms suffered by people suffering from the disease, factors, diagnosis, errors in the dosage and treatment of renal failure. A bibliographic study was carried out based on the research and interpretation of different scientific articles, highlighting the pharmacokinetic factors to start renal treatment. The most common errors attributed to patients suffering from renal failure are smoking, poor diet, diabetes, high blood pressure. It is concluded that it is essential for the biochemist to carry out a pharmacovigilance follow-up of the patient, since he/she must comply with the prescription in order to be able to cope with the disease.